Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Expedeon logo — Experts in innovative life sciences and diagnostics solution...

Expedeon

Experts in innovative life sciences and diagnostics solutions for all your research and manufacturing needs

Founded 2002 1001-5000 employees Debt Financing Total: $5.24M Biotechnology, Life Sciences

General Information

Company Name Expedeon
Founded Year 2002
Employees 1001-5000
Industries Biotechnology, Life Sciences
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Expedeon. To contact Expedeon, visit expedeon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Expedeon compare?

A PDF of Expedeon and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Expedeon soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Expedeon

Expedeon is a biotechnology and life sciences startup focusing on innovative reagents and services. Established in 2002, the company offers a wide range of solutions for protein electrophoresis, liquid biopsy, whole genome amplification, antibody- and protein-labeling, and immunoassay development. Its portfolio includes ready-to-use products and customized services, catering to the needs of scientists from academic institutions to commercial manufacturers. Expedeon, owned by SYGNIS AG, operates in the UK, USA, Singapore, Germany, and Spain. The company received a £5.00M debt financing investment from BOOST&Co on 30 August 2018. The company's commitment to delivering high-quality, user-friendly, and cost-effective solutions positions it well to capitalize on the growing demand for innovative life sciences and diagnostics solutions. With its global delivery capabilities and a focus on reducing hands-on time for researchers, Expedeon is poised for continued growth and success in the industry.

Business keywords: Life Sciences, Diagnostics, Innovative Reagents, Protein Electrophoresis, Liquid Biopsy, Genomics, Proteomics, Antibody Labeling, Bioconjugation, Nanoparticle Conjugation, Customized Services, Quality Control Testing, Global Delivery, Research and Development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing £5.00M 1
BOOST&Co
BOOST&Co
30 Aug 2018
Venture Round £240.00K 1
Santander Corporate & Commercial
Santander Corporate & Commercial
22 Sep 2014

Expedeon Alternatives & Competitors

View All Alternatives
Expedeon vs
KTK BIOTECH
KTK BIOTECH Turkey

Episozyme

1 employees
Biotechnology, Life Sciences
Expedeon vs
CYANAGEN S.R.L.
CYANAGEN S.R.L.

DNA/RNA Extraction kits, Chemiluminescence Substrates for Wester blotting & Fluorescent Reagents for...

Grant
18 employees
Biotechnology, Life Sciences
Expedeon vs
trenzyme GmbH
trenzyme GmbH Germany

As full service provider for the life science industry, we have a clear mission: Accelerating your i...

22 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Expedeon

Experts in innovative life sciences and diagnostics solutions for all your research and manufacturing needs
Expedeon was founded in 2002.
Expedeon operates in Biotechnology and Life Sciences. Its work centres on Life Sciences, Diagnostics, Innovative Reagents and Protein Electrophoresis.
Expedeon has approximately 1001-5000 employees.
Expedeon has completed 2 funding rounds, raising a total of $5.24M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Expedeon include KTK BIOTECH , CYANAGEN S.R.L., trenzyme GmbH, InDevR, Inc., Pepmic Co., Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Expedeon and KTK BIOTECH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Expedeon, https://bouncewatch.com/company/expedeon, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout